• Tidak ada hasil yang ditemukan

PHARMACY BULLETIN

N/A
N/A
Protected

Academic year: 2024

Membagikan "PHARMACY BULLETIN"

Copied!
2
0
0

Teks penuh

(1)

Beginning 27th March 2012, PPUKM Pharmacy Department started a new service. This service, also known as Perkhidmatan Panggil dan Ambil (PDA), is provided at the Pediatric, O&G and Nephrology/SLE (PON) Satellite Pharmacy located at the main lobby of UKM Medical Center.

CALL & COLLECT (C&C) PHARMACY SERVICE

PHARMACY BULLETIN

VOLUME 13, ISSUE 3 2012

WHO

are

QUALIFIED

for this service?

√ Patients with repeat prescriptions, who obtain their medication supplies from Pediatric/O&G/Nephrology & SLE (PON) Satellite Pharmacy.

√ Patients with ‘free of charge (FOC)’ payment status.

√ Patients whose prescriptions do not need amendment.

√ Duration of prescription more than 2 months.

√ Prescription must not contain Psychotropic or Dangerous Drugs.

HOW to REGISTER for the C&C service?

To use this service, patients have to register their names and registration number (RN) by filling in reg-

istration form available at the Paediatric/O&G/

Nephrology & SLE Pharmacy

Registered patients then need to call the pharmacy (hotline no.: 03-91455428), give their names and RN

to the staff, and set the date of their medications collection.

On collection day (Monday to Friday, 8:00 a.m. to 4:45 p.m.), patients are requested to give their ap-

pointment card to Counter 6 at the Pharmacy to collect their medications.

With the tagline of

Cubalah Perkhidmatan Ini, Anda Pasti Akan Berpuas Hati,

this new service aims to reduce patients’

waiting time and offers flexibility to pa- tients in determining their medications

collection date.

Up till today, Paediatric/O&G/

Nephrology & SLE Pharmacy has re- ceived registrations for 50 patients. The

pharmacy is looking forward to having

more registrations soon.

(2)

UNIT OF CONVERSION

FAQ ON TETANUS PROPHYLAXIS INJECTION

Q 1: What is the time frame to give antitetanus injection after the infection/wound has occur?

A 1: It is important to ascertain the number of doses of tetanus toxoid previously given and the interval since the last dose. Tetanus prophylaxis is required as soon as possible for patients who did not receive complete course of tetanus immunization (3 jabs) or in patients who last received their tetanus booster more than 10 years ago.

Below is the summary of tetanus prophylaxis.

Q 2 : How is the vaccination schedule like?

A 2 : A series of 3 doses of 0.5ml tetanus toxoid elicits protection in 90% vaccines. Primary vaccination provides protection at least 10 years. In children, primary immunization is given at age 2,4,6 and 15 to 18 months but the first dose can be administered as soon as 6 weeks. In children >7 years old &

adult who have NOT been immunized before, the 3 doses are administered IM initially. The first two doses are given 1-2 months a part, and the third dose is given 6-12 months after the second dose.

Q 3 : When do booster doses be given?

A 3 : Booster doses are recommended every 10 years, unless there is a contraindication to diphtheria toxoid.

References :

1. http://www.cdc.gov/mmwr/pdf/rr/rr5503.pdf

2. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.pdf

A publication of : DRUG INFORMATION CENTRE

Pharmacy Department UKM Medical Centre Izyan Diyana ibrahim

Ext 5415 [email protected] Michelle Tan Hwee Pheng

Ext 5401 [email protected]

http://

pharmacy.hukm.ukm.my

F OR Y OUR D RUG I NFORMATION

NO Description of Drug Brand Units Conversion

1.

SULODEXIDE 250 LSU CAP VESSEL DUE F 1 mg = 10 LSU, hence 1 cap = 25mg of sulodexide

2

POLYMYXIN B 500,000 U INJ X—GEN 1 mg = 10, 000 U OF Polymyxin B , hence

I vial = 50mg Polymyxin B

3

HUMAN SOMATROPIN NORDITROPIN NORDILET 1 mg = 3IU, hence in 1 Nordilet pen 5mg = 15 IU

4

FILGRASTIM G-CSF 30MIU/

ML INJ

NEUPOGEN 1 mcg = 0.1 MIU, hence in 1 vial of Neupogen = 30 MIU = 300 mcg

History of tetanus toxoid Clean, minor All other

Vaccination history Tetanus toxoid Tetanus immune globulin Tetanus toxoid Tetanus immune globulin

Unknown or < 3 doses YES NO YES YES

3 or > doses NO NO NO NO

Referensi

Dokumen terkait

However, over time it has been recognized that patients with non-brain cancers such as breast cancer, who do not receive radia- tion to the brain, may also report cognitive changes,

Nevertheless, it may be used as a last resort or a link to extracorporeal life support in patients who suffer from pulmonary hypertension or acute right ventricular failure.26